Achieves development milestones required to complete Series A financing – Plans to file Phase 2 investigational new drug (IND) application by year end, with first patient dosing in Q1 2023… Read More
Positive pivotal top-line data demonstrates 20-valent pneumococcal conjugate vaccine candidate (20vPnC), if approved, can likely help protect against all 20 vaccine serotypes in three-dose series and potentially offer the broadest… Read More
British Columbians are benefiting from post-secondary research projects that are helping create jobs, protect biodiversity and the environment, and keep people healthy and safe. “As part of our StrongerBC Economic Plan and… Read More
Health Research BC’s funding for 71 researchers through the 2022 Scholar and Research Trainee competitions will help develop, attract and retain BC’s best and brightest health researchers and support the… Read More
VANCOUVER, BC — Life Sciences BC (LSBC) is pleased to announce new and returning members to the Board of Directors, following its Annual General Meeting (AGM) held on September 15th,… Read More
